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Eicosapentaenoic acid suppresses angiogenesis via reducing 
secretion of IL-6 and VEGF from colon cancer-associated 
fibroblasts. 
(colon cancer-associated fibroblastから産生される IL-6と VEGFに対
する EPA の抑制効果とそれに伴う血管新生抑制） 
 








  主査： 片岡 洋望 





Eicosapentaenoic acid (EPA) has certain effects on improving hypercytokinemia of 
interleukin (IL)-6 in advanced cancer patients. This causes several kinds of anti-cancer 
effects. While the effects of EPA on cancer cells have been investigated, especially in terms of 
angiogenesis, its effects on the tumor stroma remain unclear. In this study, we clarified the 
role of EPA in cancer angiogenesis against colon cancer-associated fibroblasts (CAFs). 
Materials and Methods 
With established human colon fibroblasts from normal colon stroma (NFs) and colon 
cancer stroma (CAFs), we evaluated IL-6 and vascular endothelial growth factor (VEGF) 
secretion with or without EPA treatment using ELISA. Signal blockage in CAFs by EPA was 
evaluated using western blotting. In vitro anti-angiogenesis effects were evaluated by the 
angiogenesis assay on Matrigel using human umbilical vein endothelial cells (HUVECs) 
cultured with the supernatant obtained from CAF cultures with or without EPA.  
Results 
IL-6 secretion was greater from CAFs (331.5 pg/ml) than from NFs (66.7 pg/ml, p < 0.001), 
and stimulation with lipopolysaccharide (LPS) resulted in greater IL-6 secretion from both 
fibroblast types than from those without LPS stimulation. While LPS stimulation increased 
VEGF secretion from these fibroblasts, EPA decreased both IL-6 and VEGF secretion from 
CAFs. Western blotting revealed that the addition of 30 μM EPA blocked the ERK 
phosphorylation signal in CAFs. Furthermore, the angiogenesis assay with Matrigel revealed 
that the CAF culture supernatants treated with EPA significantly suppressed tubular 
formation in HUVECs.  
General significance 
EPA significantly reduced both IL-6 and VEGF secretion from CAFs. These reductions 
were caused due to the blockage of ERK phosphorylation by EPA. Thus, EPA reduces cancer 
angiogenesis associated with CAFs. 
 
